Pooph: The Pet Odor Remover that Takes Stink Out of the Equation
Pooph, which is based on BioLargo’s proprietary odor control
technology, is marketed by Ikigai Marketing Works, LLC through a national
advertising campaign (see www.Pooph.com). Walmart
is the first retailer for a planned national retail distribution, and begins
with Pooph in over 600 stores across the United States.
Jane Pak, CEO of Ikigai commented, “Sales of Pooph have
exceeded our expectations and forecasting. Availability of Pooph at 681 Walmart
stores is just the beginning of what we expect to be national retail distribution.
The team at BioLargo have been great at supporting our success. Our team is
excited to continue watching Pooph become solidified as a nationally known and
trusted consumer packaged goods brand.”
Dennis P. Calvert, President and CEO of BioLargo said, “The
team at Ikigai has continued to grow sales and brand awareness with its highly
effective marketing that showcases the product’s complete and rapid odor
elimination, and its safety. We are
thankful for the very talented team at Ikigai and look forward to working
closely with them to support their continued expansion.”
About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) invents, develops, and
commercializes innovative technologies in the cleantech space, including for
PFAS contamination, advanced water and wastewater treatment, industrial odor
and VOC control, air quality control, and infection control. With over 13 years
of extensive R&D, BioLargo holds a wide array of issued patents, maintains
a robust pipeline of products, and provides full-service environmental
engineering. Our approach is to invent or acquire novel technologies and
develop them to maturity through our operating subsidiaries. We have developed
a number of key channel partnerships to support the reach of our products and
services and maximize their commercial potential. With a keen emphasis on
collaborations with academic, municipal, and commercial organizations and
associations, BioLargo has proven itself with over 90 awarded grants and
numerous pilot projects. We monetize through direct sales, recurring service
contracts, licensing agreements, strategic joint venture formation and/or the
sale of the IP. See our website at www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements include without limitation those about
BioLargo’s (the “Company”) expectations regarding the impact of the COVID-19
pandemic; anticipated revenue; and plans for future operations. These
statements involve risks and uncertainties, and actual results may differ
materially from any future results expressed or implied by the forward-looking
statements. Risks and uncertainties include without limitation: the effect of
the COVID-19 pandemic on the Company’s business, results of operations,
financial condition, and stock price; the effect of regional economic
conditions on the Company’s business, including effects on purchasing decisions
by consumers and businesses; the ability of the Company to compete in markets
that are highly competitive and subject to rapid technological change; the
ability of the Company to manage frequent introductions and transitions of
products and services, including delivering to the marketplace, and stimulating
customer demand for, new products, services, and technological innovations on a
timely basis; the dependency of the Company on the performance of distributors
of the Company’s products. More information on these risks and other potential
factors that could affect the Company’s business and financial results is
included in the Company’s filings with the SEC, including in the “Risk Factors”
and “Management’s Discussion and Analysis of Financial Condition and Results of
Operations” sections of the Company’s most recently filed periodic reports on
Form 10-K and Form 10-Q and subsequent filings. The Company assumes no
obligation to update any forward-looking statements or information, which speak
as of their respective dates.
No comments:
Post a Comment